−0.0807 USD
−1.82 M USD
0.00 USD
687.33 M
About Propanc Biopharma, Inc.
Sector
Industry
CEO
James Andrew Nathanielsz
Website
Headquarters
Camberwell
Founded
2007
FIGI
BBG0020863R5
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PPCB is 0.0003 USD — it has decreased by −25.00% in the past 24 hours. Watch Propanc Biopharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Propanc Biopharma, Inc. stocks are traded under the ticker PPCB.
PPCB stock hasn't changed in a week, the month change is a −14.29% fall, over the last year Propanc Biopharma, Inc. has showed a −97.78% decrease.
PPCB reached its all-time high on Feb 25, 2020 with the price of 80,000.0000 USD, and its all-time low was 0.0002 USD and was reached on Sep 25, 2024. View more price dynamics on PPCB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PPCB stock is 33.33% volatile and has beta coefficient of 0.20. Track Propanc Biopharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Propanc Biopharma, Inc. there?
Today Propanc Biopharma, Inc. has the market capitalization of 206.41 K, it has decreased by −12.50% over the last week.
Yes, you can track Propanc Biopharma, Inc. financials in yearly and quarterly reports right on TradingView.
PPCB net income for the last quarter is −358.58 K USD, while the quarter before that showed −526.70 K USD of net income which accounts for 31.92% change. Track more Propanc Biopharma, Inc. financial stats to get the full picture.
No, PPCB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2024, the company has 2.00 employees. See our rating of the largest employees — is Propanc Biopharma, Inc. on this list?
Like other stocks, PPCB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Propanc Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Propanc Biopharma, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Propanc Biopharma, Inc. stock shows the sell signal. See more of Propanc Biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.